TLA Services for Oncology

Cergentis provides services based on its proprietary TLA technologies for targeted complete Next Generation Sequencing of genes of interest. Service projects are always designed and executed in close consultation with our customers.


Our service projects consist of:

  • TLA prep and enrichment
  • NGS prep and sequencing
  • Data analysis
  • Reporting


We can provide services for genes such as BRCA1,2, MLL, ETV6, RUNX1, NTRK1, NRG1, MYC, BCL2, BCL6. Our services can also be tailored to any additional enes of interest, or combinations thereof.


Generated sequence data can be transferred upon request.



Our services for oncology

  • Tailored to any combination of (additional) genes of interest
  • Suitable for FFPE, cells and gDNA
  • Defined in close consultation with customer
© 2012-2021 Cergentis B.V. All rights reserved.
For Research Use Only.Not for use in diagnostic procedures.